Anchor Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $131K | Sell |
250
-946
| -79% | -$497K | 0.01% | 434 |
|
2025
Q1 | $759K | Buy |
1,196
+191
| +19% | +$121K | 0.07% | 213 |
|
2024
Q4 | $716K | Buy |
1,005
+147
| +17% | +$105K | 0.07% | 218 |
|
2024
Q3 | $902K | Buy |
858
+583
| +212% | +$613K | 0.09% | 195 |
|
2024
Q2 | $289K | Sell |
275
-1,185
| -81% | -$1.25M | 0.03% | 295 |
|
2024
Q1 | $1.41M | Buy |
1,460
+80
| +6% | +$77K | 0.15% | 149 |
|
2023
Q4 | $1.21M | Buy |
1,380
+181
| +15% | +$159K | 0.14% | 154 |
|
2023
Q3 | $987K | Buy |
1,199
+168
| +16% | +$138K | 0.13% | 159 |
|
2023
Q2 | $741K | Buy |
1,031
+261
| +34% | +$188K | 0.09% | 184 |
|
2023
Q1 | $633K | Buy |
770
+38
| +5% | +$31.2K | 0.09% | 208 |
|
2022
Q4 | $528K | Sell |
732
-327
| -31% | -$236K | 0.08% | 223 |
|
2022
Q3 | $730K | Buy |
1,059
+149
| +16% | +$103K | 0.11% | 175 |
|
2022
Q2 | $538K | Buy |
910
+50
| +6% | +$29.6K | 0.08% | 212 |
|
2022
Q1 | $601K | Buy |
860
+85
| +11% | +$59.4K | 0.08% | 224 |
|
2021
Q4 | $489K | Buy |
775
+182
| +31% | +$115K | 0.06% | 251 |
|
2021
Q3 | $359K | Sell |
593
-87
| -13% | -$52.7K | 0.05% | 274 |
|
2021
Q2 | $380K | Sell |
680
-221
| -25% | -$123K | 0.05% | 270 |
|
2021
Q1 | $426K | Buy |
901
+826
| +1,101% | +$391K | 0.06% | 231 |
|
2020
Q4 | $36.2K | Buy |
75
+35
| +88% | +$16.9K | 0.01% | 518 |
|
2020
Q3 | $22.4K | Buy |
+40
| New | +$22.4K | ﹤0.01% | 549 |
|
2019
Q4 | – | Sell |
-10
| Closed | -$2.77K | – | 844 |
|
2019
Q3 | $2.77K | Hold |
10
| – | – | ﹤0.01% | 737 |
|
2019
Q2 | $3.13K | Sell |
10
-25
| -71% | -$7.83K | ﹤0.01% | 723 |
|
2019
Q1 | $14.4K | Buy |
35
+25
| +250% | +$10.3K | ﹤0.01% | 595 |
|
2018
Q4 | $3.74K | Hold |
10
| – | – | ﹤0.01% | 717 |
|
2018
Q3 | $4.04K | Hold |
10
| – | – | ﹤0.01% | 739 |
|
2018
Q2 | $3.45K | Sell |
10
-346
| -97% | -$119K | ﹤0.01% | 766 |
|
2018
Q1 | $123K | Buy |
356
+324
| +1,013% | +$112K | 0.03% | 361 |
|
2017
Q4 | $12K | Buy |
32
+7
| +28% | +$2.63K | ﹤0.01% | 617 |
|
2017
Q3 | $11.2K | Buy |
+25
| New | +$11.2K | ﹤0.01% | 608 |
|